FDA Commissioner Dr. Marty Makary on streamlining approvals for biosimilar generic drugs

Department of Health and Human Services has announced a plan to speed up the approval of bioimilar generic drugs and a plan to try and help lower health care costs. Joining us right now with the details is FDA Commissioner Dr. . Marty McCary.And Dr. . McCary, thank you for being with us today. Let's talk through what you guys are talk what what you are doing at this point.Um, how's it going to help. >> Well, good morning Becky and Andrew. So uh the fastest area of growth of healthcare spending in the United ...